-
Global Nulojix Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034
29 Jan 2025 17:20 GMT
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
LONDON, GREATER LONDON, UNITED KINGDOM, January 30, 2025 /EINPresswire.com/ -- How has the nulojix market grown and what factors have …
-
Albumin Market To Increase From USD 5.7 Billion In 2023 To USD 9.8 Billion By 2032
30 Jan 2025 07:02 GMT
… develop the company's share, revenue, market value, and competitive …
•Merck KGaA
•Novozymes
•Biotest AG
•Bristol-Myers Squibb Company
•Other Key Players.
Regional … -growth segments.
- Includes market share analysis of leading players, company …
-
Biological Drugs Strategic Research Report 2024: Market to Reach $634.4 Billion by 2030, Driven by Global Expansion of Healthcare Infrastructure and Rising Prevalence of Chronic Diseases - ResearchAndMarkets.com
29 Jan 2025 19:52 GMT
… Baxter International, Inc., Biogen, Inc., Bristol-Myers Squibb Company and more.
Complimentary Updates … Global Key Competitors Percentage Market Share in 2024 (E)
Competitive … International, Inc.
Biogen, Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company …
-
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
29 Jan 2025 18:00 GMT
… practices, emerging BRAF inhibitors, market share of individual therapies, and current … grab the BRAF inhibitor market share @ BRAF Inhibitor Market Report … Fabre, Jiangsu Hengrui Medicine Co., Bristol-Myers Squibb, Surface Oncology, Inhibrx, Sinocelltech, …
-
Atrial Fibrillation Drugs Market Size to Worth USD 62.64 Billion by 2033 | Straits Research
29 Jan 2025 13:50 GMT
… and capture a larger market share. Regional Analysis North America is … segment owns the largest market share and is expected to expand …
ARCA Biopharma
Baxter International Inc.
Bristol-Myers Squibb
Gilead Sciences
HUYA Biosciences
Janssen …
-
CAR T-Cell Therapies Market to Surge from USD 4.3 Billion in 2023 to USD 35.2 Billion by 2032, Growing at a 26.0% CAGR
29 Jan 2025 13:08 GMT
…
• Gilead Sciences, Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• Johnson & Johnson Services … , commanding a 24.2% market share owing to its success in … 2023 with an estimated market share of 63.8%, with the …
-
Gastrointestinal Stromal Tumor Market to See Robust Growth by 2034, Predicts DelveInsight
29 Jan 2025 12:50 GMT
… , AB Science, Immunicum AB, Novartis, Bristol-Myers Squibb, and others.
• The Gastrointestinal Stromal … the drugs based on market share.
The report also covers the …
4. Gastrointestinal Stromal Tumor Patient Share (%) Overview at a Glance …
-
BioAge Drops Lead Obesity Asset Months After IPO
28 Jan 2025 22:46 GMT
… the last ten years, with Bristol-Myers Squibb and Roche both going after … , now trading at $5 per share, down from an original $18 …
-
Women in Science: Émilie Barré on her passion for applying data to real-world challenges
28 Jan 2025 17:14 GMT
… value at One2Treat, Émilie Barré shares her journey to date with … to a large pharma company (Bristol-Myers Squibb) where I worked as a … everything I do.
Could you share some advice for young women …
-
Breast Cancer Market To Reach USD 49.2 Billion By 2032 | AstraZeneca, Pfizer Inc., Merck & Co, Sanofi, Novartis AG
28 Jan 2025 11:13 GMT
… develop the company's share, revenue, market value, and competitive … Players:
• Mylan Laboratories
• AstraZeneca
• Celltrion
• Bristol-Myers Squibb
• Fresenius Kabi
• Eisai Co. Ltd … , holding a significant 37% revenue share in 2022. The region’s …
About
© 1995-2025